PD-1 downregulation enhances CAR-T cell antitumor efficiency by preserving a cell memory phenotype and reducing exhaustion - Ouyang, Wanyan; Jin, Shi-Wei; Xu, Nan; Liu, Wei-Yang; Zhao, Han; Zhang, Liuqingqing; Kang, Liqing; Tao, Yi; Liu, Yuanfang; Wang, Yan; Wang, Jin; Liu, Feng; et al. (Journal for immunotherapy of cancer, 2024)
Keywords: Antigens; Bone marrow; Cells; Clinical trials; Cytokines; Cytotoxicity; Disease; Flow cytometry; Immune cell therapies and immune cell engineering; Immunotherapy; Lymphocytes; Metabolism; Multiple Myeloma; Receptors, Chimeric Antigen; Tumors; Receptors, Chimeric Antigen; Immunotherapy; Multiple Myeloma